Time to recurrence and survival in triple negative early-stage breast cancer

被引：0

作者：

Gerson, R. ^{[1
]}

Villalobos, A. ^{[1
]}

Alban, L. ^{[1
]}

Serrano, A. ^{[1
]}

机构：

[1] ABC Med Ctr, Mexico City, DF, Mexico

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

21151

引用

页数：1

共 50 条

[31] Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer [J].

Hao, Xiaopeng ;

Gao, Xianqi ;

Yin, Shanshan ;

Jiang, Zefei .

TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4

[32] MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer [J].

Mustafa Kahraman ;

Anne Röske ;

Thomas Laufer ;

Tobias Fehlmann ;

Christina Backes ;

Fabian Kern ;

Jochen Kohlhaas ;

Hannah Schrörs ;

Anna Saiz ;

Cassandra Zabler ;

Nicole Ludwig ;

Peter A. Fasching ;

Reiner Strick ;

Matthias Rübner ;

Matthias W. Beckmann ;

Eckart Meese ;

Andreas Keller ;

Michael G. Schrauder .

Scientific Reports, 8

[33] Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer [J].

Yu, Zhigang .

TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5

[34] The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer [J].

Duan, Fangfang ;

Zhong, Muyi ;

Ye, Jinhui ;

Wang, Li ;

Jiang, Chang ;

Yuan, Zhongyu ;

Bi, Xiwen ;

Huang, Jiajia .

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10

[35] MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer [J].

Kahraman, Mustafa ;

Roeske, Anne ;

Laufer, Thomas ;

Fehlmann, Tobias ;

Backes, Christina ;

Kern, Fabian ;

Kohlhaas, Jochen ;

Schroers, Hannah ;

Saiz, Anna ;

Zabler, Cassandra ;

Ludwig, Nicole ;

Fasching, Peter A. ;

Strick, Reiner ;

Ruebner, Matthias ;

Beckmann, Matthias W. ;

Meese, Eckart ;

Keller, Andreas ;

Schrauder, Michael G. .

SCIENTIFIC REPORTS, 2018, 8

[36] MUC1 expression in early-stage triple-negative breast cancer [J].

Miedler, J. ;

Abdul-Karim, F. ;

Wang, N. ;

Baar, J. .

CANCER RESEARCH, 2009, 69 (02) :207S-207S

[37] Effect of body mass index on survival outcome among women with early-stage, triple-negative breast cancer [J].

Dawood, S. S. ;

Lei, X. ;

Litton, J. K. ;

Buchholz, T. A. ;

Hortobagyi, G. N. ;

Gonzalez-Angulo, A. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[38] Risk of recurrence and economic burden of early-stage, triple-negative breast cancer in a US-managed care setting [J].

Xie, L. ;

Wei, W. ;

Henk, H. J. ;

Baser, O. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[39] Prognostic markers of time to local recurrence and overall survival in early-stage rectal cancer [J].

Patel, Sagar A. ;

Chen, Yu-Hui ;

Hornick, Jason L. ;

Catalano, Paul J. ;

Nowak, Jonathan ;

Zukerberg, Lawrence R. ;

Hong, Theodore S. ;

Mamon, Harvey J. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)

[40] HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer [J].

Ma, Youzhao ;

Jiao, Dechuang ;

Zhang, Jingyang ;

Lv, Minhao ;

Chen, Xiuchun ;

Liu, Zhenzhen .

ONCOLOGIST, 2024, 29 (03) :E309-E318

← 1 2 3 4 5 →